Buy, Sell or Hold: WELL Health Technologies (WELL-T)

TSE:WELL

3.15

0.08 (2.61%) 1d

Showing 1 to 15 of 28 entries

WATCH

Doesn't see them going into medical marijuana. They're looking for businesses they can easily absorb and expand their distribution. They're doing very well now. Has owned this in the past and is watching it. Is waiting for the market to stabilize.

Healthcare

HOLD

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Valuation has come to down significantly. Greater focus on organic growth. Potential to be a long-term dominant player. Taken on more debt.

Healthcare

DON'T BUY

Covered his short in June, as it had fallen too far, too fast. If it stays expensive, it may end up a hedge for him again. If it starts growing into its valuation, it could be a long. It's down to the metrics. Right now, he'd avoid.

Healthcare

BUY

It should continue to integrate the telehealth side with traditional medicine. Got extended during the pandemic and has come back down to earth. Once the rotation from shareholders is over, the stock will continue to build a base on earnings and then move up. Recent numbers were decent and he has re-added.

Healthcare

DON'T BUY

Not a profitable company that will struggle with rising interest rates. Better places for capital. Wait until later date to invest. Business model in the long term will survive (healthcare will always be required).

Healthcare

WATCH

It continues to grow and execute and management has delivered, but the market isn't interested in this type of stock. It did a recent acquisition and financial raise. It is building a digital platform for doctors - patient records etc.

Healthcare

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. EPS of $0.03 beat estimates and revenues were also ahead of expectations at $115.68M. Revenues increased 573% yoy for the quarter. Management expects 2022 revenues to top $500M and the company should be profitable. Very good results. Unlock Premium - Try 5i Free

Healthcare

DON'T BUY

The founding CEO has an excellent track record. He owned his previous company which did well. The valuation ripped higher and got ahead of itself--not their fault. However, in healthcare tech, there are names with better PEs.

Healthcare

COMMENT

Is in the online health service business, a huge growth area. It's a younger growth story without great cash flow but well positioned in Canada in the online health field. Doesn't own but is on his radar screen.

Healthcare

HOLD

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock price should not go below $3. 5i did not expect shares to go this low. Investors are not reacting to fundamentals recently. Nothing has changed for the company. More acquisitions should happen. Management is following their 5 year plan and doing a good job. Unlock Premium - Try 5i Free

Healthcare

HOLD

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The fundamental outlook has not changed. Their acquisition from 2021 is still to be proven. Sentiment is shifting towards telehealth with covid being less of a concern. Revenu growth should be good in 2022. The company is moving closer to profitability. Unlock Premium - Try 5i Free

Healthcare

HOLD

Electronic medical record software. Expectations are very high. Still in growth mode, so not profitable. Street's target is $11, with 60% growth expected next year. Overall, healthcare IT is an interesting space. Lots of competition. A hold. More research required before buying.

Healthcare

BUY on WEAKNESS

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The entire sector has been weak. Investors have some reservations about dilution from the aggressive acquisition strategy. Still comfortable with the stock in the longer term. Unlock Premium - Try 5i Free

Healthcare

WEAK BUY

With covid, WELL and other tele health came into the spotlight. Their prices appreciated quickly. Now, we are seeing a move away with more competition and the vaccine. In terms of investing, there are better opportunities elsewhere. A good company in an industry that is growing, however.

Healthcare

DON'T BUY

Telehealth player, with more of an unfocused strategy. Whereas AKU is very focused.

Healthcare

Showing 1 to 15 of 28 entries

WELL Health Technologies(WELL-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 3

Neutral - Hold Signals / Votes : 4

Bearish - Sell Signals / Votes : 3

Total Signals / Votes : 10

Stockchase rating for WELL Health Technologies is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

WELL Health Technologies(WELL-T) Frequently Asked Questions

What is WELL Health Technologies stock symbol?

WELL Health Technologies is a Canadian stock, trading under the symbol WELL-T on the Toronto Stock Exchange (WELL-CT). It is usually referred to as TSX:WELL or WELL-T

Is WELL Health Technologies a buy or a sell?

In the last year, 10 stock analysts published opinions about WELL-T. 3 analysts recommended to BUY the stock. 3 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for WELL Health Technologies.

Is WELL Health Technologies a good investment or a top pick?

WELL Health Technologies was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for WELL Health Technologies.

Why is WELL Health Technologies stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is WELL Health Technologies worth watching?

10 stock analysts on Stockchase covered WELL Health Technologies In the last year. It is a trending stock that is worth watching.

What is WELL Health Technologies stock price?

On 2022-09-28, WELL Health Technologies (WELL-T) stock closed at a price of $3.15.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.